Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Assets
Unrestricted cash and cash equivalents	$ 48,855	$ 51,033
Restricted cash and cash equivalents	18,180	20,547
Loans and fees receivable:
Loans and fees receivable, net (of $17,649 and $16,721 in deferred revenue and $19,919 and $21,474 in allowances for uncollectible loans and fees receivable at March 31, 2016 and December 31, 2015, respectively)	151,661	141,949
Loans and fees receivable, at fair value	6,275	6,353
Loans and fees receivable pledged as collateral under structured financings, at fair value	17,461	20,353
Rental merchandise, net of depreciation	1,832	4,666
Property at cost, net of depreciation	4,948	5,686
Investment in equity-method investee	9,525	10,123
Deposits	620	825
Prepaid expenses and other assets	19,958	19,194
Total assets	279,315	280,729
Liabilities
Accounts payable and accrued expenses	57,621	51,722
Notes Payable to Bank	80,834	90,000
Notes Payable, Related Parties	20,000	20,000
Notes payable associated with structured financings, at fair value	18,069	20,970
Convertible senior notes	64,910	64,783
Income tax liability	22,276	22,303
Total liabilities	$ 263,710	$ 269,778
Commitments and contingencies (Note 9)
Equity
Common stock, no par value, 150,000,000 shares authorized: 15,331,727 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at March 31, 2016; and 15,332,041 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at December 31, 2015	$ 0	$ 0
Additional paid-in capital	210,881	211,083
Accumulated other comprehensive loss	(300)	(600)
Retained deficit	(194,971)	(199,524)
Total shareholders’ equity	15,610	10,959
Noncontrolling interests	(5)	(8)
Total equity	15,605	10,951
Total liabilities and equity	$ 279,315	$ 280,729